Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Neuraxis (NRXS) EBIAT (2022 - 2025)

Neuraxis' EBIAT history spans 4 years, with the latest figure at -$2.1 million for Q3 2025.

  • For Q3 2025, EBIAT fell 20.94% year-over-year to -$2.1 million; the TTM value through Sep 2025 reached -$7.5 million, up 10.09%, while the annual FY2024 figure was -$8.2 million, 43.65% up from the prior year.
  • EBIAT for Q3 2025 was -$2.1 million at Neuraxis, down from -$1.7 million in the prior quarter.
  • Across five years, EBIAT topped out at -$13628.0 in Q4 2022 and bottomed at -$4.9 million in Q3 2023.
  • The 4-year median for EBIAT is -$2.1 million (2022), against an average of -$2.1 million.
  • The largest annual shift saw EBIAT crashed 11584.02% in 2023 before it skyrocketed 64.21% in 2024.
  • A 4-year view of EBIAT shows it stood at -$13628.0 in 2022, then plummeted by 11584.02% to -$1.6 million in 2023, then increased by 9.07% to -$1.4 million in 2024, then crashed by 46.61% to -$2.1 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's EBIAT are -$2.1 million (Q3 2025), -$1.7 million (Q2 2025), and -$2.3 million (Q1 2025).